Department of Urology, Yeungnam University College of Medicine, Daegu, Korea.
Department of Urology, Korea University School of Medicine, Seoul, Korea.
Cancer Res Treat. 2016 Jan;48(1):273-80. doi: 10.4143/crt.2014.190. Epub 2015 Mar 2.
The purpose of this study was to calculate the operating characteristics of narrowband imaging (NBI) cystoscopy versus traditional white light cystoscopy (WLC) in common clinical scenarios involving suspicion of bladder urothelial carcinoma (UC).
Sixty-three consecutive patients initially underwent WLC and then NBI in a single session for evaluation of microscopic hematuria (group I, n=20), gross hematuria (group II, n=19), and follow-up for prior UC (group III, n=24), by an experienced urologist. All lesions that were abnormal in contrast with adjacent normal mucosa were diagnosed as positive and biopsied.
Sixty-six biopsies from 47 patients were performed. Pathologic examination showed 17 cases of UC from 21 sites. While the overall sensitivity of NBI was similar to that of WLC (100% vs. 94.1%), the specificity of NBI was significantly lower than that of WLC (50% vs. 86.9%, p < 0.001), particularly in group III (38.9% vs. 88.9%, p=0.004). Based on identification by NBI only, 23 additional biopsies from 18 cases were performed for identification of one patient with UC, who belonged to group III. In this group, to identify this specific patient, 15 additional biopsies were performed from 10 patients. All seven cases with positive findings from NBI within 2 months after the last intravesical therapy were histologically proven as negative.
In evaluation for recurrence early after intravesical instillation, the decision based on NBI increased unnecessary biopsy in the absence of an established standard for judging NBI.
本研究旨在计算窄带成像(NBI)膀胱镜检查与传统白光膀胱镜检查(WLC)在常见临床情况下的诊断性能,这些情况涉及对怀疑患有膀胱尿路上皮癌(UC)的患者进行检查。
63 例连续患者最初在单次检查中同时接受 WLC 和 NBI 检查,用于评估显微镜血尿(组 I,n=20)、肉眼血尿(组 II,n=19)和先前 UC 的随访(组 III,n=24),由一位经验丰富的泌尿科医生进行检查。与相邻正常黏膜相比,所有异常的病变均被诊断为阳性并进行活检。
47 例患者的 66 个活检部位进行了病理检查。病理检查显示 21 个部位中有 17 例 UC。虽然 NBI 的总体敏感性与 WLC 相似(100%对 94.1%),但 NBI 的特异性明显低于 WLC(50%对 86.9%,p<0.001),特别是在组 III(38.9%对 88.9%,p=0.004)。仅根据 NBI 识别,对 18 例患者中的 23 个额外部位进行了活检,以识别一名属于组 III 的 UC 患者。在该组中,为了识别这名特定患者,对 10 名患者中的 15 个额外部位进行了活检。在最后一次膀胱内治疗后 2 个月内,NBI 发现的 7 例阳性病例均经组织学证实为阴性。
在膀胱内灌注后早期复发的评估中,在没有确定判断 NBI 的标准的情况下,基于 NBI 的决策增加了不必要的活检。